Freeport-McMoRan, Inc. vs Air Products and Chemicals, Inc — Stock Comparison
Q·Score Breakdown
8.4
Buy
Overall
5.7
Hold
Quality
Health
Growth
Valuation
Sentiment
FCX
Clean balance sheet with low leverage (0.3× debt-to-equity).
APD
Positive growth trajectory.
⚠ currently unprofitable (-3% margin).
Analyst Consensus
BUY
Target $67.90 (+18.3%)
21 analysts
BUY
Target $317.57 (+5.9%)
21 analysts
Fundamentals
FCX
APD
30.4×
Trailing P/E
—
15.5×
Forward P/E
21.2×
10.3%
Profit Margin
-2.7%
37.1%
Gross Margin
31.6%
15.6%
ROE
-1.7%
8.8%
Revenue Growth
5.8%
154.0%
Earnings Growth
9.7%
1.47
Beta
0.81
—
Price / Book
—
$82.4B
Market Cap
$66.8B
$35 – $71
52-Week Range
$229 – $307
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.